STAC Intervention for Health Equity
Trial Summary
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on more than two blood pressure medications.
What data supports the effectiveness of the STAC treatment for health equity?
Research shows that interventions focusing on patient empowerment and cultural leverage can improve health outcomes and reduce disparities, especially in communities of color. These approaches have been effective in managing chronic conditions like diabetes and HIV by enhancing patient engagement and tailoring care to cultural needs.12345
What is the purpose of this trial?
This study is being done to adapt the Staying Healthy After Childbirth (STAC) intervention for implementation among Black Women and Birthing Persons (WBP).
Research Team
Kara Hoppe, DO, PhD
Principal Investigator
University of Wisconsin, Madison
Andrew Garbacz, PhD
Principal Investigator
University of Wisconsin, Madison
Eligibility Criteria
This trial is for Black Women and Birthing Persons (WBP) who are dealing with high blood pressure during or after pregnancy. The study aims to adapt the STAC intervention specifically for this group to improve health equity.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-implementation Interviews
Conduct interviews with STAC-CAB members and Lived Experience Group members to evaluate implementation factors and priorities for adaptation of STAC.
Focus Groups and PDSA Cycle 1
Conduct small focus groups and the first PDSA cycle with follow-up interviews and surveys for patients and CBO staff.
PDSA Cycle 2 and Finalization
Repeat PDSA cycle and incorporate usability data to refine and finalize the A-STAC intervention.
Follow-up
Participants are monitored for feedback on the finalized A-STAC intervention.
Treatment Details
Interventions
- STAC
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator